Abstract
Biochemical iron overload (IO) is a frequent metabolic abnormality. It may be caused by several diseases, and data regarding the relative frequency of these are scant. A single diagnostic protocol including clinical, biochemical, and genetic data was used to diagnose the cause of biochemical IO in a group of 150 patients referred by general practitioners. Severe alterations of the HFE gene (42 patients, 28%), hepatitis C virus infection (33 patients, 22%), and dysmetabolic syndrome with iron overload (DSIO) (22 patients, 15%) emerged as the main causes, and other single causes were found in 20 patients (13%). In 19 patients (13%), multiple causes of IO were found, and in 14 patients no cause was found, 5 of whom had classical criteria of genetic hemochromatosis (GH) without HFE mutations. Transferrin saturation index (TSI) had a very low positive predictive value (0.16) for GH among patients with biochemical IO in this setting. In conclusion, 90% of patients with biochemical IO were diagnosed with a specific disorder. GH, hepatitis C infection, and DSIO were the major causes, and a large group of patients had multiple causes of IO. TSI is not a useful indicator of GH in patients referred by general practitioners.
Similar content being viewed by others
References
Altes A, Gimferrer E, Capella G, Barcelo MJ, Baiget M (1999) Colorectal cancer and HFE gene mutations. Haematologica 84:479–480
Altes A, Souto JC, Mateo J, Borrell M, Fontcuberta J (1997) Activated protein C resistance assay when applied in the general population. Am J Obstet Gynecol 176:358–359
Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH (1999) Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 116:193–207
Baiget M, Barcelo MJ, Gimferrer E (1998) Frequency of the HFE C282Y and H63D mutation in distinct ethnic groups living in Spain. J Med Gen 35:701
Beard J (2001) Iron status of free-living elderly individuals Am J Clin Nutr 73:503–504
Bonkovsky HL, Jawaid Q, Tortorelli K, LeClair P, Cobb J, Lambrecht RW, Banner BF (1999) Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Heptatol 31:421–429
Bonkovsky HL, Ponka P, Bacon BR, Drysdale J, Grace ND, Tavill AS (1996) An update on iron metabolism: summary of the fifth international conference on disorders of iron metabolism. Hepatology 24:718–729
Dadone MM, Kushner JP, Edwards CQ, Bishop DT, Skolnick MH (1982) Hereditary hemochromatosis. Analysis of the laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol 78:196–207
EASL International Consensus Conference on Haemochromatosis (2000) J Hepatol 33:485–504
Fargion S, Mattioli M, Francanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G (2001) Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 96:2448–2455
Farinati F, Carin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R (1995) Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 22:449–456
Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408
Fleming DJ, Jacques PF, Tucker KL, Massaro JM, D'Agostino RB SR, Wilson PW, Wood RJ (2001) Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr 73:638–646
Gandon Y, Guyader D, Heautot JF, Reda MI, Yaouanq J, Buhe T, Brissot P, Carsin M, Deugnier Y (1994) Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 193:533–538
George DK, Goldwurm S, Macdonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW (1998) Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311–318
Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK (2002) A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology122:646–651
Hezode Ch, Cazeneuve C, Coue O, Roudot-Thoraval F, Lonjon I, Bastie A, Duvoux C, Pawlotsky JM, Zafrani ES, Amselem S, Dhumeaux D (1999) Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. J Hepatol 31:979–984
Kazemi-Shirazi L, Datz Ch, Maier-Dobersberger T, Kaserer K, Hackl F, Polli C, Steindl PE, Penner E, Ferenci P (1999) The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 116:127–134
Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW (1990) Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 74:525–530
Mendler M, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guyader D, Le Gall JY, Brissot P, David V, Deugnier Y (1999) Insulin resistance-associated hepatic iron overload. Gastroenterology 117:1155–1163
Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y (1997) A new syndrome of liver iron overload with normal transferrin saturation. Lancet 349:95–97
Nielsen P, Günther U, Dürken M, Fischer R, Düllmann (2000) Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance. J Lab Clin Med 135:413–418
Porter JB (2001) Practical management of iron overload Br J Haematol 115:239–252
Remacha AF, Carrasco M, Sarda MP, Barcelo MJ, Baiget M (1999) HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload. Haematologica 84:284–285
Remacha AF, Carrasco M, Sarda MP, Barceló MJ, Blesa I, Baiget M (2000) Screening for iron overload and HFE mutations in a university hospital. Haematologica 85:873–874
Smith BC, Grove J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF (1998) Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 27:1695–1699
Thorburn D, Curry G, Spooner R, Spence E, Oien K, Halls D, Fiox R, McCruden EA, McSween RN, Mills PR (2002) The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 50:248–252
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Altes, A., Remacha, A.F., Sureda, A. et al. Patients with biochemical iron overload: causes and characteristics of a cohort of 150 cases. Ann Hematol 82, 127–130 (2003). https://doi.org/10.1007/s00277-002-0595-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-002-0595-8